James Vollins's Net Worth
$289 Thousand
Who is James Vollins?
James Vollins does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, and Eiger BioPharmaceuticals, Inc..
SEC CIK
James Vollins's CIK is 0001757833
Past Insider Trading and Trends
2020 was James Vollins's most active year for acquiring shares with 6 total transactions. James Vollins's most active month to acquire stocks was the month of December. 2022 was James Vollins's most active year for disposing of shares, totalling 11 transactions. James Vollins's most active month to dispose stocks was the month of February. 2022 saw James Vollins paying a total of $249,999.24 for 443,522 shares, this is the most they've acquired in one year. In 2019 James Vollins cashed out on 59,650 shares for a total of $181,634.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
See RemarksJames Vollins used to own units in Common Stock but no longer holds any shares there.acquired a total of 125,698 shares in BIODELIVERY SCIENCES INTERNATIONAL INC at a cost of $290,886.40, James also disposed a total of 125,698 shares of BIODELIVERY SCIENCES INTERNATIONAL INC equalling to $579,710.26.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
| -100.00% | -28.41K |
$3.62 | -$102,879.12 |
0
|
Scheduled
|
Feb 4
| ||
Form 4
|
∞
| 28.41K |
—
|
—
| 28.41K |
Jan 27 - Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
| -100.00% | -12.14K |
$4.03 | -$48,908.19 |
0
|
Scheduled
|
Feb 4 - Feb 8
| ||
Form 4
|
∞
| 12.14K |
—
|
—
| 12.14K |
Jan 29 - Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
$3.97 | -$30,015.10 |
0
|
Dec 14 - Dec 16
| |||
Form 4
|
—
|
0
|
$4.25 | -$15,166.20 |
0
|
May 21
| |||
Form 4
| -100.00% | -3.83K |
$3.50 | -$13,415.50 |
0
|
Mar 16
| |||
Form 4
|
∞
| 3.83K |
—
|
—
| 3.83K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
$4.78 | -$78,439.75 |
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eiger BioPharmaceuticals, Inc. (EIGR) No price found
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||